Mira Leiwant RAC

Mira Leiwant currently serves as Vice President of Regulatory Affairs for Interventional Oncology at BTG International. She has overall responsibility for EU MDR implementation for all of BTG’s medical device products. She has over 20 years’ experience in the medical device industry, spanning several functional areas from R&D to Quality Assurance and Regulatory Affairs, for products in the therapeutic areas of cardiology, wound care, regenerative medicine and oncology. She earned both Bachelor’s and Master’s degrees in Mechanical Engineering from Cornell University, and holds a Regulatory Affairs Certification.